Acrivon Therapeutics
ACRV
$5.80
Share price
-4.29%
Change (1 day)
-55.62%
Change (1 year)
Categories
Acrivon Therapeutics (ACRV) - P/B ratio
P/B ratio as of June 2024 : 1.73
According to Acrivon Therapeutics's latest financial reports the company has a price-to-book ratio of 1.73.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Acrivon Therapeutics - P/B ratio (from 2022 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 0.9010 | -36.16% |
| 2022-12-31 | 1.41 | |
| 2021-12-31 | N/A |